Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1B | P49286 | 18/20 | 0.61 |
| ▸ | MTNR1A | P48039 | 17/20 | 0.61 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6676394 | 1.00 | MTNR1B (0.61) | MTNR1BMTNR1ASLC6A4 | |
| SCHEMBL6677678 | 0.85 | MTNR1B (0.64) | MTNR1BMTNR1ASLC6A4 | |
| SCHEMBL6677674 | 0.85 | MTNR1B (0.64) | MTNR1BMTNR1ASLC6A4 | |
| SCHEMBL6679783 | 0.85 | MTNR1B (0.53) | MTNR1BMTNR1ASLC6A4 | |
| SCHEMBL6679785 | 0.85 | MTNR1B (0.53) | MTNR1BMTNR1ASLC6A4 | |
| SCHEMBL6682138 | 0.81 | MTNR1B (0.65) | MTNR1BMTNR1ASLC6A4 | |
| SCHEMBL6682142 | 0.81 | MTNR1B (0.65) | MTNR1BMTNR1ASLC6A4 | |
| SCHEMBL6682371 | 0.81 | MTNR1B (0.59) | MTNR1BMTNR1ASLC6A4 | |
| SCHEMBL6679663 | 0.78 | MTNR1B (0.55) | MTNR1BMTNR1ASLC6A4 | |
| SCHEMBL6780444 | 0.76 | MTNR1A (1.00) | MTNR1BMTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1027043-B1 | BENZODIOXOLE, BENZOFURAN, DIHYDROBENZOFURAN, AND BENZODIOXANE MELATONERGIC AGENTS | BRISTOL MYERS SQUIBB CO (US) | 2004-11-10 | — | — | EP | disclosed |
| US-6060506-A | FOR TREATMENT OF SLEEP DISORDERS, CIRCADIAN RHYTHM DISORDERS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2000-05-09 | — | — | US | disclosed |
| US-5981571-A | USEFUL AS MELATONERGIC AGENTS IN THE TREATMENT OF SLEEP DISORDERS, SEASONAL DEPRESSION, SHIFTS IN CIRCADIAN CYCLES, MELANCHOLIA, STRESS, APPETITE REGULATION, BENIGN PROSTATIC HYPERPLASIA AND RELATED CONDITIONS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-11-09 | — | — | US | disclosed |